Pharma analysts see little threat from Clinton plan to rein-in drug costs
September 22, 2015 at 17:35 PM EDT
Hillary Rodham Clinton's plan to rein in prescription drug prices by reshaping how drugmakers do business is being met by skepticism within the industry.
